Pharmaceutical Supply Chain Intelligence
Analysis of global API ecosystems, biologics manufacturing expansion, capacity investment and international distribution strategy.
Supply stability and manufacturing scale are strategic determinants in rare disease and oncology drug accessibility.
Counterfeit Cancer Drugs, Weight-Loss Medications, and ED Pills: The Growing Global Threat to Patient Safety
May 27, 2026
Counterfeit cancer drugs, fake PD-1 therapies, counterfeit GLP-1 weight-loss medications, and fake ED pills are creating growing risks for patient safety worldwide.
Lilly’s Triple Agonist Retatrutide Shows Promising Phase III Results: Up to 2% HbA1c Reduction and Nearly 17% Weight Loss
May 27, 2026
Eli Lilly’s Retatrutide demonstrated significant HbA1c reduction and weight-loss efficacy in Phase III diabetes trials, accelerating the transition toward the triple agonist era in metabolic disease treatment.
How AI Reshapes Drug R&D: A Full-Chain Innovation from Target Discovery to Clinical Trials
May 26, 2026
Artificial intelligence is reshaping pharmaceutical R&D from target discovery to clinical trial optimization, accelerating innovation across the entire drug development chain.
Eli Lilly’s Retatrutide Phase 3 Data Shocks the Market: Behind the 30% Weight Loss, the Peptide API Supply Chain Emerges as a New Hotspot
May 26, 2026
Eli Lilly’s Retatrutide Phase 3 data is reshaping the obesity drug market while accelerating global demand for peptide API manufacturing and supply chain capacity.
How Pharmaceutical Distributors Respond to Transportation Requirements for Different Dosage Forms
May 23, 2026
How pharmaceutical distributors manage transportation requirements for different dosage forms, including tablets, injectables, biologics, lyophilized drugs, and advanced therapies.
How Big Is the Difference Between Dosage Forms of the Same Drug?
May 19, 2026
Explore how different pharmaceutical dosage forms affect therapeutic outcomes, drug delivery, patient adherence, cold-chain logistics, and global pharmaceutical supply systems.
Metformin Immediate-Release, Enteric-Coated, and Extended-Release Tablets: Do They Have the Same Blood Sugar-Lowering Effect?
May 19, 2026
Learn the differences between immediate-release, enteric-coated, and extended-release metformin tablets, including blood sugar control, gastrointestinal side effects, convenience, and long-term diabetes management.
Oral Dissolving Films: A New Dosage Form Transforming the Modern Medication Experience
May 19, 2026
Explore how oral dissolving films (ODFs) are transforming modern medication delivery with improved convenience, faster absorption, and better patient experience.
Global Pharmaceutical Market Under Policy Influence: Reshaping the Landscape and Future Opportunities
May 07, 2026
How pharmaceutical policies are reshaping the global market, influencing innovation, pricing, compliance, and future opportunities in the healthcare industry.
BCMA-Targeted ADC Therapy: A New Direction for Precision Treatment of Multiple Myeloma
April 30, 2026
China’s Innovative Drugs Going Global: What Does $57.1 Billion in BD Deals Mean?
April 28, 2026
China’s innovative drug outbound BD deals reach $57.1B, signaling a shift toward global competitiveness and integrated supply chain capabilities.
From R&D to Accessibility: Innovative Medicines Empower the Upgrade of Global Health Systems
April 28, 2026
Innovative medicines are reshaping global health systems, but accessibility remains a key challenge. Exploring the full pathway from R&D to patient access.
China Innovative Drug Weekly: RNA, ADC, CAR-T and GLP-1 Drive Global Expansion
April 15, 2026
Weekly update on China’s innovative drug landscape covering RNA therapies, ADC, CAR-T, GLP-1 and global expansion trends.
Chinese-Listed Pharmaceuticals Going Global: New Trends in the International Accessibility of Specialty Drugs
April 14, 2026
How Chinese-listed pharmaceuticals are expanding globally and improving international access to specialty drugs through supply chain innovation.
Global Pharmaceutical Supply Network: A Core Engine Driving Medical Innovation and Accessibility
April 13, 2026
How global pharmaceutical supply networks are enabling innovation, compliance, and patient access in the era of advanced therapies.
Geopolitics and Pricing Systems Reshaping Global Pharmaceutical Competition
April 10, 2026
Enhancing Resilience and Transparency in Pharmaceutical Supply Chains
April 09, 2026
Innovation Drug Technology and R&D Trends: From Platform-Based Innovation to Global Supply Chain Synergy
April 09, 2026
Global Pharmaceutical Market Outlook 2026: How Obesity and Oncology Drugs Are Driving the Next Growth Breakthrough
April 08, 2026
Cross-Border Pharmaceutical Distribution: A Core Trend in Global Healthcare Systems
March 28, 2026